These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 1686300)

  • 1. In vivo assessment of release and metabolism of dopamine in the ventrolateral striatum of awake rats following administration of dopamine D1 and D2 receptor agonists and antagonists.
    See RE; Sorg BA; Chapman MA; Kalivas PW
    Neuropharmacology; 1991 Dec; 30(12A):1269-74. PubMed ID: 1686300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of acetylcholine release by D1, D2 dopamine receptors in rat striatum under freely moving conditions.
    Ajima A; Yamaguchi T; Kato T
    Brain Res; 1990 Jun; 518(1-2):193-8. PubMed ID: 1975213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of in vivo dopamine release by D2 but not D1 receptor agonists and antagonists.
    Boyar WC; Altar CA
    J Neurochem; 1987 Mar; 48(3):824-31. PubMed ID: 2949060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective unilateral inactivation of striatal D1 and D2 dopamine receptor subtypes by EEDQ: turning behavior elicited by D2 dopamine receptor agonists.
    Giorgi O; Biggio G
    Brain Res; 1990 Nov; 533(1):53-9. PubMed ID: 1982234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The D1 agonist SKF 38393 increases dopamine release in the developing rat striatum.
    Walters DE; Howard SG
    Eur J Pharmacol; 1990 Aug; 184(2-3):257-64. PubMed ID: 2150376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of dopamine D-1 and D-2 receptor selective drugs on dopamine release and metabolism in rat striatum in vivo.
    Zetterström T; Sharp T; Ungerstedt U
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Oct; 334(2):117-24. PubMed ID: 2946964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of D1 and D2 dopamine receptors in oral stereotypy induced by dopaminergic stimulation of the ventrolateral striatum.
    Delfs JM; Kelley AE
    Neuroscience; 1990; 39(1):59-67. PubMed ID: 1982467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Similar pharmacological properties of 8-OH-DPAT and alnespirone (S 20499) at dopamine receptors: comparison with buspirone.
    Protais P; Lesourd M; Comoy E
    Eur J Pharmacol; 1998 Jul; 352(2-3):179-87. PubMed ID: 9716353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential regulation of striatal preproenkephalin mRNA by D1 and D2 dopamine receptors.
    Pollack AE; Wooten GF
    Brain Res Mol Brain Res; 1992 Jan; 12(1-3):111-9. PubMed ID: 1312196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The regulation of dopamine release from nigrostriatal neurons in conscious rats: the role of somatodendritic autoreceptors.
    Santiago M; Westerink BH
    Eur J Pharmacol; 1991 Oct; 204(1):79-85. PubMed ID: 1687125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation.
    Hu XT; White FJ
    Synapse; 1992 Mar; 10(3):206-16. PubMed ID: 1532677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pressure reversed extracellular striatal dopamine decrease produced by D1 receptor agonist SKF 38393, and D2 receptor agonist LY 171555, but failed to change the effect of the activation of both D1 and D2 receptors.
    Abraini JH; Fechtali T; Rostain JC
    Neuroscience; 1992 Sep; 50(2):395-402. PubMed ID: 1359460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. D1-like and D2-like dopamine receptors synergistically activate rotation and c-fos expression in the dopamine-depleted striatum in a rat model of Parkinson's disease.
    Paul ML; Graybiel AM; David JC; Robertson HA
    J Neurosci; 1992 Oct; 12(10):3729-42. PubMed ID: 1357113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Striatal dopamine metabolism increases during long-term haloperidol administration in rats but shows tolerance in response to acute challenge with raclopride.
    See RE
    Neurosci Lett; 1991 Aug; 129(2):265-8. PubMed ID: 1720879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alpha 1 (but not alpha 2)-adrenoceptor agonists in combination with the dopamine D2 agonist quinpirole produce locomotor stimulation in dopamine-depleted mice.
    Eshel G; Ross SB; Kelder D; Edis LE; Jackson DM
    Pharmacol Toxicol; 1990 Aug; 67(2):123-31. PubMed ID: 1979437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the interaction between D1 and D2 receptors in a drug discrimination paradigm.
    Williams JE; Sutherland JV; Woolverton WL
    Behav Neural Biol; 1990 May; 53(3):378-92. PubMed ID: 1972014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of inactivation of D1 dopamine receptors on stereotypic and thermic responses to quinpirole (LY 171555).
    Double KL; Crocker AD
    Neurosci Lett; 1990 Jul; 115(1):81-5. PubMed ID: 1977110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repeated stimulation of D1 dopamine receptors causes time-dependent alterations in the sensitivity of both D1 and D2 dopamine receptors within the rat striatum.
    Hu XT; Brooderson RJ; White FJ
    Neuroscience; 1992 Sep; 50(1):137-47. PubMed ID: 1357592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopamine depletion preferentially impairs D1- over D2-receptor regulation of striatal in vivo acetylcholine release.
    Bertorelli R; Zambelli M; Di Chiara G; Consolo S
    J Neurochem; 1992 Jul; 59(1):353-7. PubMed ID: 1351928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced response to the inhibitory action of LY171555, a dopamine D2-agonist, on in vivo striatal dopamine release in DOCA/NaCl-hypertensive rats.
    Chen YF; Oparil S
    Brain Res; 1987 Jan; 400(2):225-31. PubMed ID: 2949797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.